According to the study, Rb1 treatment (80 μM) for 24 h decreased IL-1β-induced NO production by 46% compared to the IL-1β treated SW1353 cells, a kind of human chondrosarcoma cell lines. Here, IL1B is linked to chondrosarcoma.